Robust Prediction of Immune Checkpoint Inhibition Therapy for Non-Small Cell Lung Cancer

Robust Prediction of Immune Checkpoint Inhibition Therapy for Non-Small Cell Lung Cancer

BackgroundThe development of immune checkpoint inhibitors (ICIs) is a revolutionary milestone in the field of immune-oncology. However, the low response rate is the major problem of ICI treatment. The recent studies showed that response rate to single-agent programmed cell death protein 1 (PD-1)/pro...

Full description

Bibliographic Details
Main Authors: Jiehan Jiang, Zheng Jin, Yiqun Zhang, Ling Peng, Yue Zhang, Zhiruo Zhu, Yaohui Wang, De Tong, Yining Yang, Jianfei Wang, Yadong Yang, Kui Xiao
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Immunology
Subjects:
immunotherapy
non-small cell lung cancer
biomarkers
immune pathway
neural network
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.646874/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.646874/full

Similar Items